4/23/24 16:26 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | M.d | 0 | 0.00 | 0 | 25 | 35 | 96 | D | | | | | | | | | | | | | | |
3/6/24 16:43 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P.d | 46 | 4.59 | 0 | 10 | 15 | 77 | D | | | | | | | | | | | | | | |
6/1/23 17:42 | 5/30/23 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P | 28 | 5.50 | 0 | 5 | 8 | 67 | D | | | | | | | | | | | | | | |
5/1/23 17:53 | 4/28/23 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | M.d | 0 | 0.00 | 0 | 8 | 14 | 62 | D | | | | | | | | | | | | | | |
4/24/23 16:13 | 4/21/23 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | M.d | 0 | 0.00 | 0 | 25 | 84 | 55 | D | | | | | | | | | | | | | | |
11/21/22 14:27 | 11/18/22 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P.d | 0 | 0.00 | 0 | 22 | 147 | 37 | D | | | | | | | | | | | | | | |
4/29/22 16:39 | 4/28/22 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | M.d | 0 | 0.00 | 0 | 8 | 172 | 12 | D | | | | | | | | | | | | | | |
8/19/21 17:11 | 8/17/21 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | M.d | 0 | 0.00 | 0 | 0 | 1 | 6 | D | | | | | | | | | | | | | | |
5/27/21 16:10 | 5/27/21 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P | 42 | 7.00 | 0 | 6 | 999% | 6 | D | | | | | | | | | | | | | | |
8/19/20 16:26 | 8/18/20 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 0 | 96 | 0 | D | | | | | | | | | | | | | | |
8/15/19 17:10 | 8/13/19 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 1 | 187 | 2 | D | | | | | | | | | | | | | | |
1/17/19 17:30 | 1/15/19 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 0 | 3 | 1 | D | | | | | | | | | | | | | | |
8/15/18 16:52 | 8/13/18 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 1 | | 1 | D | | | | | | | | | | | | | | |
9/12/17 14:30 | 9/8/17 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | O | CFO | M.d | 0 | 0.00 | 0 | 0 | 50 | 1 | D | | | | | | | | | | | | | | |
1/12/17 11:42 | 1/10/17 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | O | CFO | M.d | 0 | 0.00 | 1 | 3 | 37 | 12 | D | -74 | -28 | -40 | 37 | 16 | 28 | 18 | -16 | 8 | -5 | -2 | -27 | | |
8/23/16 18:16 | 8/19/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | O | CFO | M.d | 0 | 0.00 | 0 | 5 | 112 | 9 | D | -82 | -77 | -5 | -36 | -41 | -36 | -34 | 12 | 0 | -9 | -17 | -19 | 5 | |
8/23/16 18:16 | 8/19/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | O | CFO | S.d | -1 | 0.5700 | 0 | -1 | -13 | 9 | D | -82 | -77 | -5 | -36 | -41 | -36 | -34 | 12 | 0 | -9 | -17 | -19 | 5 | |
3/16/16 18:29 | 3/14/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | O | CFO | M.d | 0 | 0.00 | 0 | 3 | 114 | 6 | D | -93 | -64 | -67 | -29 | 34 | 32 | 11 | 6 | -4 | -6 | 1 | 31 | -36 | -38 |
3/16/16 18:29 | 3/15/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | O | CFO | S.d | -1 | 0.8300 | 0 | -1 | -12 | 6 | D | -93 | -64 | -67 | -29 | 34 | 32 | 11 | 6 | -4 | -6 | 1 | 31 | -36 | -38 |
8/20/15 13:03 | 8/18/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | O | CFO | M.d | 0 | 0.00 | 4 | 5 | | 4 | D | -68 | -14 | 24 | 48 | 33 | -14 | -13 | -5 | -11 | -24 | 4 | -16 | -79 | -80 |
8/20/15 13:03 | 8/18/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | O | CFO | S.d | -4 | 2.76 | 4 | -1 | -29 | 4 | D | -68 | -14 | 24 | 48 | 33 | -14 | -13 | -5 | -11 | -24 | 4 | -16 | -79 | -80 |